-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the Shaanxi Provincial Public Resources Trading Center issued a notice on the cancellation of the qualification of some products to be listed on the Internet
.
The notice shows that products that fail to declare the lowest price in the country as required to be listed on the Internet will be disqualified from being listed on the Internet and recorded in the company's integrity file
.
Among them, Chongqing Yaoyou Pharmaceutical, Sichuan Meida Kanghuakang Pharmaceutical, Hainan Sanye Pharmaceutical Factory, Suicheng Pharmaceutical, Beijing Sihuan Kebao Pharmaceutical, Harbin Songhe Pharmaceutical, Zhaoke Pharmaceutical, etc.
Industry (Hefei), Zhejiang Xilinte Pharmaceutical, these 8 companies, involving 9 products including Yanhuning for injection, lipoic acid injection, famotidine for injection, and nadroparin calcium for injection
.
It is understood that the notice of Shaanxi Province on the cancellation of the eligibility of some products to be listed on the Internet was made in accordance with the "Implementation Plan for the Dynamic Adjustment of the Drug Sunshine Network of the Shaanxi Provincial Public Resource Trading Center"
.
The "Plan" clearly states that "if there is a new national minimum price for products in the list of price-limited listings, the production enterprises that are listed on the net must declare to the provincial platform within 1 month from the date when the price is implemented
.
Failure to timely or If it is declared truthfully, once it is verified, the qualification of the product to be listed on the Internet will be cancelled and recorded in the integrity file of the enterprise, and the declaration of the product will not be accepted within one year
.
” Recently, in addition to Shanxi Province, many provinces have withdrawn a batch of medicines from the Internet because of the price
.
For example, in the "Notice on Price Correction and Price Restriction of Some Drugs" issued by the Medicine Price and Bidding and Purchasing Office of Hunan Provincial Medical Insurance Bureau, there is a big difference in the price of the same listing catalog (especially in different periods).
10 drugs, such as famotidine, whose prices were inflated by real-name reports, were significantly different in price and quality, and were reported to be inflated by their real names, were listed on the Internet with price corrections and price limits
.
Prior to this, the Sichuan Provincial Medicine and Equipment Recruitment and Procurement Center had withdrawn from the network 186 products that concealed the lowest listing price/bidding price (Tibet price) in the country
.
The drugs withdrawn include lidocaine hydrochloride injection, ornidazole tablets, ribavirin tablets and other commonly used clinical western medicines, as well as Chinese patent medicines such as Niuhuangjiedu tablets and Banlangen granules.
.
In addition, in mid-January, the Pharmaceutical Price and Bidding and Purchasing Office of Hunan Provincial Medical Insurance Bureau issued the "Notice on Price Correction and Price Restriction of Some Drugs on the Internet".
10 drugs, including famotidine, whose prices were inflated by real-name reports, were significantly different in price and quality, and were reported to be inflated by real names, were listed on the Internet with price corrections and price limits
.
From the above point of view, the implementation of drug price correction and price limit listing has become an effective means to solve the falsely high drug prices and rectify the order of the pharmaceutical market
.
Industry analysts believe that, according to the "14th Five-Year Plan" for National Medical Security issued by the State Council, a comprehensive monitoring mechanism for the procurement price information of drugs and medical consumables in public medical institutions and a transaction price information sharing mechanism will be established to increase the price of drugs and medical consumables.
From the perspective of the ability to analyze, early warning and respond to abnormal changes, strengthening the normalized supervision of the prices of drugs and medical consumables will become a key task for the country and even all regions
.
In the future, if companies want to keep their eligibility for listing on the Internet, they must regularly sort out the data of the trading platforms in each province, and adjust the prices of their own products in a timely manner according to regulations
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
The notice shows that products that fail to declare the lowest price in the country as required to be listed on the Internet will be disqualified from being listed on the Internet and recorded in the company's integrity file
.
Among them, Chongqing Yaoyou Pharmaceutical, Sichuan Meida Kanghuakang Pharmaceutical, Hainan Sanye Pharmaceutical Factory, Suicheng Pharmaceutical, Beijing Sihuan Kebao Pharmaceutical, Harbin Songhe Pharmaceutical, Zhaoke Pharmaceutical, etc.
Industry (Hefei), Zhejiang Xilinte Pharmaceutical, these 8 companies, involving 9 products including Yanhuning for injection, lipoic acid injection, famotidine for injection, and nadroparin calcium for injection
.
It is understood that the notice of Shaanxi Province on the cancellation of the eligibility of some products to be listed on the Internet was made in accordance with the "Implementation Plan for the Dynamic Adjustment of the Drug Sunshine Network of the Shaanxi Provincial Public Resource Trading Center"
.
The "Plan" clearly states that "if there is a new national minimum price for products in the list of price-limited listings, the production enterprises that are listed on the net must declare to the provincial platform within 1 month from the date when the price is implemented
.
Failure to timely or If it is declared truthfully, once it is verified, the qualification of the product to be listed on the Internet will be cancelled and recorded in the integrity file of the enterprise, and the declaration of the product will not be accepted within one year
.
” Recently, in addition to Shanxi Province, many provinces have withdrawn a batch of medicines from the Internet because of the price
.
For example, in the "Notice on Price Correction and Price Restriction of Some Drugs" issued by the Medicine Price and Bidding and Purchasing Office of Hunan Provincial Medical Insurance Bureau, there is a big difference in the price of the same listing catalog (especially in different periods).
10 drugs, such as famotidine, whose prices were inflated by real-name reports, were significantly different in price and quality, and were reported to be inflated by their real names, were listed on the Internet with price corrections and price limits
.
Prior to this, the Sichuan Provincial Medicine and Equipment Recruitment and Procurement Center had withdrawn from the network 186 products that concealed the lowest listing price/bidding price (Tibet price) in the country
.
The drugs withdrawn include lidocaine hydrochloride injection, ornidazole tablets, ribavirin tablets and other commonly used clinical western medicines, as well as Chinese patent medicines such as Niuhuangjiedu tablets and Banlangen granules.
.
In addition, in mid-January, the Pharmaceutical Price and Bidding and Purchasing Office of Hunan Provincial Medical Insurance Bureau issued the "Notice on Price Correction and Price Restriction of Some Drugs on the Internet".
10 drugs, including famotidine, whose prices were inflated by real-name reports, were significantly different in price and quality, and were reported to be inflated by real names, were listed on the Internet with price corrections and price limits
.
From the above point of view, the implementation of drug price correction and price limit listing has become an effective means to solve the falsely high drug prices and rectify the order of the pharmaceutical market
.
Industry analysts believe that, according to the "14th Five-Year Plan" for National Medical Security issued by the State Council, a comprehensive monitoring mechanism for the procurement price information of drugs and medical consumables in public medical institutions and a transaction price information sharing mechanism will be established to increase the price of drugs and medical consumables.
From the perspective of the ability to analyze, early warning and respond to abnormal changes, strengthening the normalized supervision of the prices of drugs and medical consumables will become a key task for the country and even all regions
.
In the future, if companies want to keep their eligibility for listing on the Internet, they must regularly sort out the data of the trading platforms in each province, and adjust the prices of their own products in a timely manner according to regulations
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
